article

Drug Target Review – Issue #3 2017

Posted: 6 September 2017 | | No comments yet

Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer’s disease; Accelerating neuroscience research with flow cytometry…

  • Foreword: The importance of industry partnerships
    Chris Watkins, Director of Innovation, Medical Research Council
  • In-Depth Focus: Assays
  • Research Area: Alzheimer’s Disease – Calcilytics as potential novel therapeutic treatments to halt Alzheimer’s disease
    Anna Chiarini, Ubaldo Armato and Ilaria Dal Prà, University of Verona
  • In-Depth Focus: Imaging
  • Stem Cells: EUTCD-Grade lines – an innovative approach to creating and supplying clinical hESC lines
    Glyn Stacey, UK Stem Cell Bank
  • Flow Cytometry: accelerating neuroscience research
    Pushpanathan Muthuirulan, National Institute of Health
  • In-Depth Focus: NGS

The digital version of issue #3 2017 is restricted to logged-in members. Login or subscribe free to read it.


Send this to a friend